UBS factors in Covid shock to stressed VAR, causing RWA surge

UBS’s market risk-weighted assets (RWAs), used to calculate regulatory capital requirements, jumped 11% to $11.8 billion in the last quarter of 2020. This was largely the result of the bank including Covid-19 period volatility to the historical dataset used to inform its stressed value-at-risk (SVAR) measure.

The bank disclosed in its Q4 report that its average SVAR – the calculation of which informs part of its overall market RWA amount – was driven up over the last three months of 2020

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: